Komla is a Scientist I at Sensorium Therapeutics, where he is responsible for building the computational pipeline used to analyze sequencing data. Prior to joining Sensorium, Komla had completed his dissertation working on new methods for testing and predicting the effect of genetic variants in polygenic disorders such as epilepsy and bronchopulmonary dysplasia. Komla holds a PhD in Biophysics and a BS in Mathematics from The Ohio State University.